Form 4 for BAX Baxter International
Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-06 · accession 0001062993-25-008900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-08 | 2025-05-06 | BAX | Oesterle Stephen N. | Dir | A - Grant | $0.00 | +7,183 | 35.8K | +25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $1 par value | 2025-05-06 | A | A | 7,183 | $0.00 | 35,847 | D | — | — | (F1) The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. (F2) Total includes the automatic reinvestment of dividends. |